author-photo

Vivienne Marsh

Onyx Pharmaceuticals

4

Papers

160

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Abstract 2515: Preclinical Development of ARRY-162, A Potent and Selective MEK 1/2 Inhibitor

2010 Cancer Research
Show All
- Source
- Cite
- Save
Citations (20)
Tetrazole and ester substituted tetrahydoquinoxalines as potent cholesteryl ester transfer protein inhibitors.

2007 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (58)
Discovery of heterocyclic ureas as a new class of raf kinase inhibitors: identification of a second generation lead by a combinatorial chemistry approach.

2001 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (78)